Low Pay And Occupational Hazards Trouble Some Industrial Chemists

To chemists arriving in San Francisco for next week's American Chemical Society meeting, Arnold Thackray, director of Philadelphia's Beckman Center for the History of Chemistry, suggests something to keep in mind. If you check into a hotel room today, he says, and you're wearing a polyester suit, "odds are everything in the room is composed of chemically processed polymers except for your body--and we're on the verge of decoding [even] that." During a time of remarkable advances, one might

Written byScott Huler
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

If you check into a hotel room today, he says, and you're wearing a polyester suit, "odds are everything in the room is composed of chemically processed polymers except for your body--and we're on the verge of decoding [even] that."

During a time of remarkable advances, one might conclude that now is a great time to be a chemist. Yet today's bleak economic conditions and a growing awareness of occupational hazards lead others to conclude the opposite.

Layoffs by companies throughout the chemical industry, low salaries, hazardous working conditions, and few changes on the horizon make optimism difficult. Says chemical consultant Mordecai Treblow, who has worked with employment issues as a member of the American Chemical Society (ACS), "The employment trend for industrial chemists is downward--there aren't any bright spots, with the possible exception of pharmaceuticals."

On the other hand, small firms are growing, technology is rapidly advancing, and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies